Interview with Tomáš Matějovský, Partner, CMS Cameron McKenna Czech…
Mr. Matějovský, let’s begin our discussion with a very simple question. The Czech Republic is quite a small country, and yet it seems to have one of the most complicated…
Address: CMS Cameron McKenna v.o.s. Palladium, Na Poříčí 1079/3a 110 00 Prague 1,Czech Republic
Tel: +420 296 798-111
Web: http://www.cms-cmck.com/Prague-Czech-Republic
The Prague office of CMS was established in 1991. The office has over 35 international and local lawyers and provides a full range of legal services to both domestic and international clients. We conduct regular independent reviews with clients and these indicate that they value our ability to combine international expertise with local knowledge.
We have significant experience in working with international and local companies, insurers, banks and financial institutions, private organizations and government authorities. CMS in Prague is considered a market leader and our experts, such as Tomáš Matějovský, receive excellent feedback from clients.
CMS Cameron McKenna has a track record of advising lifesciences businesses throughout Central and Eastern Europe. We have been established in the region for more than twenty years, which means we never underestimate the differences between local markets, whilst taking into account EU and EEA standards.
Over the past years sector regulations in the region have undergone significant changes – from the rules on marketing pharmaceutical and healthcare products to legislation relating to medical devices. The changes have had a profound effect on the way business is conducted in CEE. We’ve made it our business to know the market inside out.
Our clients tell us that we have the in-depth knowledge they need to support their businesses across the region. We speak the industry’s language and our cross-regional lifesciences practice comprises 50+ lawyers advising some of the sector’s major players and representatives.
Mr. Matějovský, let’s begin our discussion with a very simple question. The Czech Republic is quite a small country, and yet it seems to have one of the most complicated…
Martin Minarovič, Janssen’s country director Czech Republic, discusses the success factors behind the company’s strong growth, not only in terms of revenue but more importantly in terms of the number…
Ladislav Drož, CEO of APIGENEX, reveals the company’s strategy to survive after a leadership change and a reshuffling of the small-molecule science operations at their main client, Novo Nordisk. Drož…
Patrik Reichl, CEO of CzechInvest, the Investment and Business Development Agency under the Ministry of Industry and Trade of the Czech Republic, breaks down the role of the agency in…
Patrik Zachar, Vice President Central Europe of Ipsen, shares how the company has built a strong presence in oncology and neuroscience in the CE region and the Czech Republic, quickly…
In 1996, Jiří Žák, chairman & current CEO of FARMAK, took over the state-owned producer of vitamins FARMAKON where he previously worked for 30 years and turned it into a…
Milan Černek, country manager of Mylan in the Czech Republic, provides expert insights into current trends in the Czech Republic’s generics and biosimilars markets, describes the affiliate’s strategy to continue…
Kieran Leahy, general manager of Takeda in the Czech Republic and Slovakia, recounts how he has led the transformation of Takeda into a specialty care organization at the local level,…
Emelie Antoni joined AstraZeneca in Sweden 20 years ago, evolving in global, regional and local roles. Last year, she became country manager for Czech Republic & Slovakia, with an ambitious…
Robin Turner, general manager of Roche Czech Republic, shares how he transformed the affiliate from a “local” company to a highly engaged member of the Roche group whilst breaking down…
Increasing consolidation and digitalization within the Czech pharmacy sector is forcing consumer healthcare firms to rethink their strategies. Pharmacy Consolidation Within the Central and Eastern European (CEE) region, the…
Darina Hrdličková, chairwoman of the Association of Contract Research Organizations in the Czech Republic (ACRO-CZ), gives an overview of her new priorities and mission since taking over the position in…
Vladimír Velebný, founder and CEO, celebrates his 30th anniversary heading Contipro, a mid-sized company with deep experience in R&D surrounding their star product, hyaluronic acid. Whilst breaking down the components…
See our Cookie Privacy Policy Here